Drug recall
Platelets, Leukocytes Reduced
FDA recall event 85012 · Class II · Rhode Island Blood Center, A Division of New York Blood Center, Inc.
Key facts
| Event ID | 85012 |
|---|---|
| Recall numbers | B-0339-2020 |
| Recalling firm | Rhode Island Blood Center, A Division of New York Blood Center, Inc. |
| Product type | Biologics |
| Products | Platelets, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Plateletpheresis product, not meeting product specifications, was distributed. |
| Initiation date | Feb 17, 2020 |
| Report date | Feb 26, 2020 |
| Termination date | Feb 19, 2020 |
| City | Providence |
| State | RI |
| Country | United States |
| FEI number | 1270007 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: